Most popular programs
Trending now
Developed by leading researchers and clinicians from across Canada, this course will enhance knowledge and skills for clinicians who are using or beginning to use a biosimilar or biologic medicine in their professional practice setting.
After a course session ends, it will be archived.
- This course aims to provide advanced knowledge and skills for health care professionals on the topic of biosimilars, a class of biologic drugs or medical therapies that are highly similar to an existing originator medication that is off patent.
- Biosimilars present a rapidly growing area in pharmaceutical development, treatment options, and patient care that require an evidence-informed implementation approach.
- As awareness and use of biosimilars increases globally, this course will provide information and guidance to support the effective and safe use of biosimilars in clinical settings among health care providers.
- The course will focus on enhancing knowledge and skills to affect change in attitude and behaviour of health care providers related to biosimilars.
- The course will utilize a modular approach to provide content that is accessible and informative to all learners, including pharmacists, physicians, nurses, students and young professionals, industry, and policy-makers.
- This course may be eligible for continuing education credits through professional accreditation bodies.
- The course will also provide learners with opportunities to develop skills in each of these knowledge areas, with the overall aim of improving patient-provider communication and perceptions of biosimilar use and establishing a consistent foundation among health care providers for communicating with patients about biosimilar treatment.
- This course will build off of the material in BSS101 to provide advanced knowledge and skills related to use and implementation of biosimilar medications in clinical settings.
This course will build off of the material in BSS101 to provide advanced knowledge and skills related to use and implementation of biosimilar medications in clinical settings.
Improve knowledge of originator biologic and biosimilar biologic medicines
Understand scientific and clinical evidence to support appropriate cost-effective application of biosimilars across oncology, rheumatology, gastrointestinal disease, and other medical conditions
Address misconceptions regarding use of biosimilars
Identify the benefits and significance of biosimilar use in clinical practice and across jurisdictions
Discuss implications of biosimilar use for clinical practice and patient education to optimize patient care and wellness
Module 1 - Understanding Biologics and Biosimilars
Learning Objectives:
1. Describe biologic medications, including how they are manufactured and how they are used in clinical practice
2. Describe biosimilar biologics, how they differ from generics and how they are used in clinical practice
3. Define inherent variability and comparability.
4. Discuss the requirements and process for demonstrating comparability of biosimilar biologics
5. Describe why biosimilar medications are important now
Module 2 - Regulatory Approval Process
Learning Objectives:
1. Describe the approval process for biosimilars in Canada, including general considerations for new drugs and special considerations for biologics
2. Compare and contrast the approval process for biosimilar biologics and originator biologics
3. Examine the safety and efficacy of biosimilars
4. Describe pharmacovigilience and adverse reporting mechanisms for originator and biosimilar biologics in Canada
5. Describe the authorization of specific indications for biosimilars
6. Distinguish interchangeability and switching in relation to biosimilars
Module 3 - Instilling confidence in patients about their care plan & ethical considerations
Learning Objectives:
1. Develop an awareness of ethics and ethical principles
2. Appreciate the ethical issues related to biosimilar biologics
3. Understand the factors that contribute to a trustworthy clinician-patient therapeutic relationship
4. Identify the communication skills needed to cultivate a trusting clinician-patient relationship, including with patients from diverse communities
5. Consider the broader structural influences on therapeutic trust within the context of biosimilar biologics
Module 4 - Discussing Biosimilars with your Patients
Learning Objectives:
1. Understand how patient expectations and beliefs impact treatment changes
2. Describe strategies to elicit patient perspectives on switching medications
3. Apply proven principles of patient-physician communication and motivational interviewing to discussions about switching medications
4. Identify strategies to create a positive mindset in patients for switching medications
"This is an ideal course to learn about biosimilars and will give you the skills to have informed and helpful conversations with patients." - Leta Forbes
"This course really helped me build confidence to discuss biosimilars with my patients in depth." - Yuxing
Who can take this course?
Unfortunately, learners residing in one or more of the following countries or regions will not be able to register for this course: Iran, Cuba and the Crimea region of Ukraine. While edX has sought licenses from the U.S. Office of Foreign Assets Control (OFAC) to offer our courses to learners in these countries and regions, the licenses we have received are not broad enough to allow us to offer this course in all locations. edX truly regrets that U.S. sanctions prevent us from offering all of our courses to everyone, no matter where they live.
Who can take this course?
Unfortunately, learners residing in one or more of the following countries or regions will not be able to register for this course: Iran, Cuba and the Crimea region of Ukraine. While edX has sought licenses from the U.S. Office of Foreign Assets Control (OFAC) to offer our courses to learners in these countries and regions, the licenses we have received are not broad enough to allow us to offer this course in all locations. edX truly regrets that U.S. sanctions prevent us from offering all of our courses to everyone, no matter where they live.
